CIK 0001829802
- Emerging growth company
Faeth Therapeutics, Inc.
Sign in to watch- Ticker
- FTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 512-200-2982
- Business address
- 701 TILLERY STREET #12 #1010, AUSTIN, TX, 78702
- Former names
- Sensei Biotherapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 12 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-25 | Cambrian BioPharma Inc 10% owner | Purchase | +12,000 | $15.79 | $189K | 4,763,794 |
| 2021-02-24 | Peyer James Director | Purchase | +18,100 | $16.84 | $305K | 4,750,894 |
| 2021-02-24 | Peyer James Director | Purchase | +900 | $18.42 | $17K | 4,751,794 |
| 2021-02-24 | Cambrian BioPharma Inc 10% owner | Purchase | +18,100 | $16.84 | $305K | 4,750,894 |
| 2021-02-24 | Cambrian BioPharma Inc 10% owner | Purchase | +900 | $18.42 | $17K | 4,751,794 |
| 2021-02-23 | Peyer James Director | Purchase | +6,000 | $17.04 | $102K | 4,718,494 |
| 2021-02-23 | Peyer James Director | Purchase | +14,300 | $18.10 | $259K | 4,732,794 |
| 2021-02-23 | Cambrian BioPharma Inc 10% owner | Purchase | +6,000 | $17.04 | $102K | 4,718,494 |
| 2021-02-23 | Cambrian BioPharma Inc 10% owner | Purchase | +14,300 | $18.10 | $259K | 4,732,794 |
| 2021-02-22 | Cambrian BioPharma Inc 10% owner | Purchase | +9,802 | $18.88 | $185K | 4,712,494 |
| 2021-02-22 | Peyer James Director | Purchase | +9,802 | $18.88 | $185K | 4,712,494 |
| 2021-02-19 | Peyer James Director | Purchase | +11,786 | $19.77 | $233K | 4,702,692 |
| 2021-02-19 | Cambrian BioPharma Inc 10% owner | Purchase | +11,786 | $19.77 | $233K | 4,702,692 |
| 2021-02-18 | Peyer James Director | Purchase | +752 | $19.75 | $15K | 4,690,905 |
| 2021-02-18 | Cambrian BioPharma Inc 10% owner | Purchase | +752 | $19.75 | $15K | 4,690,905 |
| 2021-02-18 | Peyer James Director | Purchase | +753 | $19.75 | $15K | 4,690,906 |
| 2021-02-18 | Cambrian BioPharma Inc 10% owner | Purchase | +753 | $19.75 | $15K | 4,690,906 |
| 2021-02-08 | RICKS THOMAS G Director | Conversion | +301,769 | 301,769 | ||
| 2021-02-08 | RICKS THOMAS G Director | Conversion · Series AA Preferred Convertible Stock | −11,447,156 | 0 | ||
| 2021-02-08 | RICKS THOMAS G Director | Conversion · Series BB Preferred Convertible Stock | −3,037,849 | 0 |
Page 19 of 20 · 385 trades